EUVIMEDEUVIMED entdecken
Fallbericht

Unraveling the Molecular and Clinical Consequences of an Intragenic TRIP12 Duplication Using Genomic and RNA Analyses

Haowei Du, Przemyslaw Szafranski, Amanda Gerard, Mahshid S Azamian, Weimin Bi iD, Mir Reza Bekheirnia, Paweł Stankiewicz iD

American Journal of Medical Genetics Part A · 2025

DOI: 10.1002/ajmg.a.64036 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Haowei Du und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Gene Duplication, Intellectual Disability. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clark–Baraitser syndrome is a rare neurodevelopmental disorder associated with the E3 ubiquitin‐protein ligase gene TRIP12 . Using chromosomal microarray analysis (CMA), long‐range PCR, breakpoint sequencing, and RNA analyses, we studied a 6‐year‐old female presenting with developmental delay, aggressive behavior, attention‐deficit hyperactivity disorder, and mild dysmorphic features. CMA revealed a de novo ~87 kb copy‐number variant (CNV) duplication at 2q36.3, involving Exons 3–14 of TRIP12 . Long‐range PCR and Sanger sequencing showed a head‐to‐tail tandem duplication with breakpoints in Introns 2 and 14. RNA analysis identified a novel splicing junction between the coding Exon 14 and the stop codon of the noncoding portion of Exon 3, resulting in a premature translation termination. This suggests the neo‐transcript undergoes nonsense‐mediated decay and/or produces a truncated protein lacking the critical E6AP‐type E3 ubiquitin–protein ligase domain. This case further highlights the challenges with the clinical interpretation of CNV gains and the usefulness of RNA sequencing in the clarification of the impacts of intragenic duplications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Protein LigasesGene DuplicationIntellectual DisabilityHumansFemaleChildDNA Copy Number VariationsDevelopmental DisabilitiesExonsGenomicsPhenotypeCarrier Proteins

Stichwörter der Autor:innen

CNV interpretationIntragenic duplicationtandem duplication

Substanzen

Ubiquitin-Protein LigasesTRIP12 protein, humanCarrier Proteins

Autor:innen und Institutionen

  • Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
  • Baylor Genetics Laboratory, Houston, Texas, USA.
  • Texas Children's Hospital, Houston, Texas, USA.
  • Department of Pediatrics, Division of Pediatric Nephrology, Baylor College of Medicine, Houston, Texas, USA.

ORCID-Profile: Weimin Bi, Paweł Stankiewicz

Zitieren

APA

Du, H., Szafranski, P., Gerard, A., Azamian, M. S., Bi, W., Bekheirnia, M. R., & Stankiewicz, P. (2025). Unraveling the Molecular and Clinical Consequences of an Intragenic TRIP12 Duplication Using Genomic and RNA Analyses. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64036

Vancouver

Du H, Szafranski P, Gerard A, Azamian MS, Bi W, Bekheirnia MR, et al. Unraveling the Molecular and Clinical Consequences of an Intragenic TRIP12 Duplication Using Genomic and RNA Analyses. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.64036

BibTeX
@article{Du2025,
  author = {Du, Haowei and Szafranski, Przemyslaw and Gerard, Amanda and Azamian, Mahshid S and Bi, Weimin and Bekheirnia, Mir Reza and Stankiewicz, Paweł},
  title = {Unraveling the Molecular and Clinical Consequences of an Intragenic TRIP12 Duplication Using Genomic and RNA Analyses},
  journal = {American Journal of Medical Genetics Part A},
  year = {2025},
  doi = {10.1002/ajmg.a.64036}
}
Kostenlos starten →